Related Experiment Video

Updated: Jun 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth

Amanda C Daly1, Pedro Vizán, Caroline S Hill

  • 1Laboratory of Developmental Signalling, Cancer Research UK London Research Institute, London WC2A 3PX, United Kingdom.

The Journal of Biological Chemistry
|December 29, 2009
PubMed

Insights

Transforming growth factor beta (TGF-beta) signaling is crucial in tumor development. This study shows reduced Smad3 protein levels in tumor cells, which is necessary for their proliferation despite TGF-beta, highlighting Smad3

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Transforming growth factor beta (TGF-beta) signaling regulates critical biological processes.
  • Aberrant TGF-beta signaling is linked to tumor development.
  • Smad3 is a key mediator in the TGF-beta pathway, regulating gene transcription.

Purpose of the Study:

  • To investigate the regulation of Smad3 during tumor development.
  • To determine the role of Smad3 protein levels in tumor cell proliferation and TGF-beta response.

Main Methods:

  • Utilized a well-characterized tumor model.
  • Compared Smad3 levels in tumorigenic and normal epithelial cells.
  • Analyzed Smad3 regulation at mRNA and protein stability levels.
  • Performed functional analysis via ectopic Smad3 expression.

Main Results:

  • Smad3 protein levels were significantly reduced in tumorigenic cells compared to normal cells.
  • Smad3 expression showed cell cycle-dependent regulation, higher in quiescent and lower in proliferating cells.
  • Down-regulation of Smad3 was essential for tumor cell proliferation in the presence of TGF-beta.
  • Restoring Smad3 levels in tumor cells re-established TGF-beta's growth inhibitory effect.

Conclusions:

  • Smad3 protein level is a critical determinant in tumorigenesis progression.
  • High Smad3 levels support TGF-beta's tumor suppressor functions.
  • Low Smad3 levels facilitate TGF-beta's tumor-promoting functions.

More Related Videos

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...